The role of weight gain in explaining the effects of antipsychotic drugs on positive and negative symptoms: An analysis of the CATIE schizophrenia trial-Reference-Cited by-同舟云学术

The role of weight gain in explaining the effects of antipsychotic drugs on positive and negative symptoms: An analysis of the CATIE schizophrenia trial

Published:2019-04 Issue: Volume:206 Page:96-102
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

Bellavia Andrea,Centorrino Franca,Jackson John W.,Fitzmaurice Garrett,Valeri Linda^ORCID

Funder

Harvard Catalyst

The Harvard Clinical and Translational Science Center

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference40 articles.

1. Antipsychotic-induced weight gain: a comprehensive research synthesis;Allison;Am. J. Psychiatry,1999

2. The moderator–mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations;Baron;J. Pers. Soc. Psychol.,1986

3. Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits;Centorrino;Am. J. Psychiatry,2004

4. Metabolic syndrome in psychiatrically hospitalized patients treated with antipsychotics and other psychotropics;Centorrino;Hum. Psychopharmacol. Clin. Exp.,2012

5. Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study;Daumit;Schizophr. Res.,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Not Only Metabolic Complications of Childhood Obesity;Nutrients;2024-02-15

2. High Rate of Discontinuation during Long-Acting Injectable Antipsychotic Treatment in Patients with Psychotic Disorders;Biomedicines;2023-01-22

3. Lurasidone versus Quetiapine for Cognitive Impairments in Young Patients with Bipolar Depression: A Randomized, Controlled Study;Pharmaceuticals;2022-11-14

4. Acne caused by ziprasidone in a young patient with bipolar disorder: A case report;Frontiers in Psychiatry;2022-11-04

5. Olanzapine‐associated dose‐dependent alterations for weight and metabolic parameters in a prospective cohort;Basic & Clinical Pharmacology & Toxicology;2022-02-17